Molecular Therapy
Volume 30, Issue 3, 2 March 2022, Pages 1329-1342
Original ArticleAn RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis
Under a Creative Commons license
open access
Graphical abstract
Keywords
Non-alcoholic steatohepatitis
NASH
RNAi therapeutics
Oligonucleotide therapy
non-alcoholic fatty liver disease
NAFLD
Cited by (0)
© 2021 The Author(s).